On June 20, 2019, Jérôme Galon, the scientific co-founder of HalioDx, received the European Inventor Award 2019 in the research category for Immunoscore®.
Jérôme is one of the 6 French researchers honoured in this category since the creation of the European Inventor Award in 2006 and is the very first one from Inserm !
French immunologist Jérôme Galon developed Immunoscore®, a diagnostics tool that helps medical staff predict the chances of recovery and risks of relapse in cancer patients based on the strength of their immune response.
“This recognition is a great news for Jérôme and his Inserm laboratory at the Cordeliers Research Centre in Paris and as well for HalioDx which focus on bringing (Immunoscore®) this breakthrough invention to patient’s bed.
After deploying the test under the most stringent existing regulations in Europe and the US, we are now focused on demonstrating the clinical utility of Immunoscore® for managing localized colon cancer. We have already published a large body of evidence to this end and as we pursue our effort, we expect the test being reimbursed by major healthcare providers in the near future.“ said Vincent Fert, CEO of HalioDx.